ah 6809 has been researched along with yohimbine in 3 studies
| Studies (ah 6809) | Trials (ah 6809) | Recent Studies (post-2010) (ah 6809) | Studies (yohimbine) | Trials (yohimbine) | Recent Studies (post-2010) (yohimbine) |
|---|---|---|---|---|---|
| 163 | 1 | 49 | 5,893 | 253 | 532 |
| Protein | Taxonomy | ah 6809 (IC50) | yohimbine (IC50) |
|---|---|---|---|
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.0353 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 1.02 | |
| D(2) dopamine receptor | Homo sapiens (human) | 2.06 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 1.3 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.0428 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 0.0466 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.126 | |
| Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0682 | |
| Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0682 | |
| Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0682 | |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 1.3 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 1.013 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.126 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.074 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 1.3 | |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 1.689 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Malinowska, B; Molderings, G; Schlicker, E | 1 |
| Berrino, L; Bräutigam, M; Griepenkerl, I; Jäger, R; Möhlig, A; Racké, K; Reimann, A | 1 |
| Heinemann, A; Holzer, P; Peskar, BA; Shahbazian, A | 1 |
3 other study(ies) available for ah 6809 and yohimbine
| Article | Year |
|---|---|
Inhibition of noradrenaline release in the rat vena cava via prostanoid receptors of the EP3-subtype.
Topics: Alprostadil; Animals; Dinoprost; Dinoprostone; Electric Stimulation; Indomethacin; Misoprostol; Norepinephrine; Prostaglandin Antagonists; Prostaglandin D2; Prostaglandins; Rats; Receptors, Prostaglandin; Receptors, Prostaglandin E; Vena Cava, Inferior; Xanthenes; Xanthones; Yohimbine | 1992 |
Modulation of noradrenaline release in rat isolated stomach by prostanoids, but not by histaminergic mechanisms.
Topics: Abortifacient Agents, Nonsteroidal; Animals; Dinoprostone; Electric Stimulation; Female; Gastric Mucosa; Histamine Agonists; Indomethacin; Methylhistamines; Misoprostol; Muscarinic Agonists; Norepinephrine; Oxotremorine; Parasympatholytics; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Receptors, Histamine; Receptors, Prostaglandin; Scopolamine; Stomach; Tetrodotoxin; Xanthenes; Xanthones; Yohimbine | 1995 |
Differential peristaltic motor effects of prostanoid (DP, EP, IP, TP) and leukotriene receptor agonists in the guinea-pig isolated small intestine.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Alprostadil; Animals; Bridged Bicyclo Compounds, Heterocyclic; Dinoprostone; Dose-Response Relationship, Drug; Fatty Acids, Unsaturated; Female; Guinea Pigs; Hydantoins; Hydrazines; Iloprost; In Vitro Techniques; Intestine, Small; Leukotriene Antagonists; Leukotriene D4; Male; Oxazepines; Peristalsis; Prostaglandin D2; Prostaglandins A; Receptors, Leukotriene; Receptors, Prostaglandin; Xanthenes; Xanthones; Yohimbine | 2002 |